nach oben

Erschienen in:

Open Access 01.12.2022 | Research article

A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis

verfasst von: Shi Yin, Xianzhe Li, Zhizhong Xiong, Minghao Xie, Longyang Jin, Huaxian Chen, Chaobin Mao, Fengxiang Zhang, Lei Lian

Erschienen in: BMC Gastroenterology | Ausgabe 1/2022

Abstract

Background

Patients with ulcerative colitis are at an increased risk of developing colorectal cancer with a prolonged disease course. Many studies have shown that alterations in the immune microenvironment play a key role in ulcerative colitis-associated colorectal cancer. Additionally, competing endogenous RNAs have important functions in immunoregulation, affecting inflammation and tumorigenesis. However, the complexity and behavioral characteristics of the competing endogenous RNA immunoregulatory network in ulcerative colitis-associated colorectal cancer remain unclear. We constructed a competing endogenous RNA immunoregulatory network to discover and validate a novel competing endogenous RNA immunoregulatory axis to provide insight into ulcerative colitis-associated colorectal cancer progression.

Methods

The competing endogenous RNA immunoregulatory network was constructed using differential expression analysis, weighted gene co-expression network analysis, and immune-related genes. Cmap was used to identify small-molecule drugs with therapeutic potential in ulcerative colitis-associated colorectal cancer. The ulcerative colitis-associated colorectal cancer-related pathways were identified by gene set variation and enrichment analysis. CIBERSORT, single-sample Gene Set Enrichment Analysis, and xCell were used to evaluate the infiltration of immune cells and screen hub immunocytes. The competing endogenous RNA immunoregulatory axis was identified by correlation analysis.

Results

We identified 130 hub immune genes and constructed a competing endogenous RNA immunoregulatory network consisting of 56 long non-coding RNAs, four microRNAs, and six targeted hub immune genes. Four small-molecule drugs exerted potential therapeutic effects by reversing the expression of hub immune genes. Pathway analysis showed that the NF-κB pathway was significantly enriched. Neutrophils were identified as hub immunocytes, and IL6ST was significantly positively correlated with the neutrophil count. In addition, NEAT1 may serve as a competing endogenous RNA to sponge miR-1-3p and promote IL6ST expression.

Conclusions

The competing endogenous RNA immunoregulatory axis may regulate neutrophil infiltration, affecting the occurrence of ulcerative colitis-associated colorectal cancer.

Additional file 1. Table S1: Number of genes in the 10 modules. Table S2: List of 130 hub immune genes.

Additional file 2. Fig. S1: shows the stem-loop structure of miRNA precursors. (A) Secondary structures of human pre‐miR‐1. (B) Secondary structures of human pre‐miR‐133a.

Supplementary Information

The online version contains supplementary material available at https://doi.org/10.1186/s12876-022-02252-7.

Shi Yin, Xianzhe Li and Zhizhong Xiong have contributed equally to this work

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

CAC

Ulcerative colitis-associated colorectal cancer

ceRNA

Competing endogenous RNA

HIGs

Hub immune genes

Ulcerative colitis

mRNA

Messenger RNA

miRNAs

Micro RNAs

IRGs

Immune-related genes

WGCNA

Weighted gene co-expression network analysis

NCBI

National Center for Biotechnology Information

GEO

Gene Expression Omnibus

Normal control

RMA

Robust multiarray average

TOM

Topological overlap matrix

MEs

Module eigengenes

Gene significance

GSEA

Gene set enrichment analysis

GSVA

Gene set variation analysis

MSigDB

Molecular Signatures Database

lncRNA

Long non-coding RNA

DEmRNAs

Differentially expressed mRNAs

DEmiRNAs

Differentially expressed miRNAs

PCA

Principal component analysis

ANOVA

After the analysis of variance

Module membership

Background

Ulcerative colitis (UC) is a chronic, recurrent, and intestinal inflammatory disease; however, its pathogenesis remains unclear. It is generally considered that the intestinal mucosal immune system of patients with UC produces abnormal amplification of the immune response to intestinal microbial antigens in a specific environment, which can cause intestinal mucosal inflammatory damage [1]. The imbalance between inflammation and mucosal immunity is an important feature of colorectal carcinogenesis [2]. Therefore, patients with UC have an increased risk of UC-associated colorectal cancer (CAC).

Although an increasing number of studies have investigated coding gene-related biomarkers in CAC, protein-coding genes only account for 2% of the human genome. The competitive regulatory crosstalk of different molecular species, especially the competition between protein-coding and non-coding RNA transcripts, is a key link in the occurrence of disease [3, 4]. MicroRNAs (miRNAs), as an abundant class of small, non-coding, single-stranded oligoribonucleotides, act as regulators in various cellular processes and function as sequence-specific silencers of target gene transcription after binding, thereby affecting the expression levels of more than half of all protein-coding genes [5, 6]. Therefore, Salmena et al. [7] proposed the competing endogenous RNA (ceRNA) hypothesis, which posits that most RNA molecules act in a “many-to-many” manner. As each miRNA molecule may potentially target miRNA response elements on multiple messenger RNA (mRNA) molecules, each mRNA molecule can be targeted by multiple miRNA molecules [8]. This suggests that miRNA molecules have a pivotal role in competitively regulating crosstalk and lead to gene silencing by binding to mRNAs, and that ceRNA regulates gene expression by competitively binding to miRNAs.

Numerous ceRNA studies in different diseases (ie tumors, inflammatory bowel diseases, liver fibrosis, and cardiovascular diseases) have suggested that ceRNA can influence dysregulation of the immune microenvironment by regulating the interaction of different types of RNAs, thereby promoting the occurrence and development of diseases [9‐15]. However, the specific immunoregulatory mechanisms in the CAC process remain unclear. We hypothesized that the ceRNA regulatory axis can alter the immune microenvironment during the development of CAC.

To verify this hypothesis, we integrated immune-related genes (IRGs), weighted gene co-expression network analysis (WGCNA), and differential expression analysis results, and then constructed a ceRNA immunoregulatory network based on the principle of reverse prediction. Subsequently, small-molecule medicines with possible applications in therapy for CAC were investigated. Pathway enrichment analysis and immune cell infiltration analysis were performed to identify the key pathways and immune cells. Correlation analysis was conducted to identify the key ceRNA regulatory axis from the network. This study provides a foundation for improving the understanding of the pathophysiological processes of CAC and insights into the variations in the immunological microenvironment of the disease.

Methods

Data acquisition and preprocessing

The research and design flowchart is shown in Fig. 1. Gene expression profiles of datasets GSE37283 [16] and GSE68306 [17] were downloaded from the National Center for Biotechnology Information (NCBI).

Gene Expression Omnibus (GEO) database (https://www.ncbi.nlm.nih.gov/geo/). The GSE37283 dataset contains mRNA microarray raw data from 20 colonic mucosal samples (five normal control [NC] samples, four UC samples, and 11 UC samples harboring remote neoplasia). The GSE68306 dataset contains miRNA normalized expression matrix data of 11 UC-associated neoplastic samples and 16 NC samples. Raw CEL data (data storage format) were parsed using the ‘affy’ package in R [18]. The robust multiarray average (RMA) algorithm background correction and quantile normalization were performed on gene expression profiles with the ‘oligo’ package in R [19]. The annotation package of the microarray platform GPL13158 was used to convert the probe IDs into gene symbols. Chip quality was assessed using the ‘arrayQualityMetrics’ package in R [20]. Moreover, 1793 IRGs were downloaded from the Immunology Database and Analysis Portal database (https://immport.niaid.nih.gov), which covers 17 immune categories [21].

Construction of weighted gene co-expression gene network

The ‘WGCNA’ package in R was used to analyze the co-expression network of the top 25% gene variants in the GSE37283 dataset [22]. The adjacency matrix was constructed by calculating Pearson’s correlation coefficient. Subsequently, a scale-free co-expression network based on the soft threshold parameter β was established. The adjacency matrix was converted to a topological overlap matrix (TOM) by comparing the weighted correlation of the two nodes with the others. Hierarchical clustering of dissimilarity TOM (dissTOM = 1 − TOM) rendered similar gene expression levels in the same gene module. Next, the dynamic cut tree algorithm was used to further partition the modules. Additionally, module eigengenes (MEs) and gene significance (GS) were used to identify modules associated with CAC. MEs represent the principal component of all gene expression levels in individual modules. GS was considered as the mediated p-value for each gene, representing the correlation between gene expression and CAC.

Differential expression analysis and identification of hub immune genes

We analyzed the differentially expressed mRNAs and miRNAs between CAC and NC samples using the classical Bayesian methodology with the ‘limma’ package in R [23]. In GSE37283, the cut-off criteria were set at p < 0.05 and |log2fold-change (FC)|> 1. In GSE68306, we adjusted the threshold of differential expression to p < 0.05 and |log2FC|> 0.5, allowing the results to be optimized. The differentially expressed mRNAs, IRGs, and CAC-related module genes in WGCNA were intersected to obtain the differentially expressed hub immune genes (HIGs), which were visualized in a Venn diagram [24].

Small-molecule drug prediction

The Cmap database (http://www.broadinstitute.org) includes and collates 6100 gene expression profiles from 7056 microarray datasets, covering 1309 Food and Drug Administration-approved small-molecule drugs [25]. The database is commonly used to predict potential drugs for treating diseases and repurposing existing drugs. Uploading the HIGs into the Cmap database resulted in connectivity scores for the corresponding small-molecule drugs with values between + 1 and − 1. A positive connectivity score indicated that the small-molecule drug induced gene expression, whereas a negative connectivity score suggested that specific drugs could reverse gene expression patterns. Therefore, the screening criteria for potential therapeutic drugs were enrichment < −0.7, and p < 0.01. The molecular structures of potential therapeutic drugs were displayed using the PubChem database (https://pubchem.ncbi.nlm.nih.gov/) [26].

Gene set enrichment analysis

Gene set enrichment analysis (GSEA) and gene set variation analysis (GSVA) are two types of gene enrichment methods [27, 28], the former estimates the enrichment of pathways in phenotypic genes according to the background gene set, whereas the latter transforms the gene expression matrix into a gene set enrichment matrix using an unsupervised method. We downloaded the hallmark gene set from the Molecular Signatures Database (MSigDB; https://www.gsea-msigdb.org/gsea/msigdb/index.jsp) for use as reference [29]. The ‘clusterpProfiler’ package in R was used for GSEA and visualization [30]. The p and q values were obtained by simulating permutations of 1000 random genomes, and p < 0.05 and q < 0.05 were used as screening criteria. For GSVA, we used the ‘gsva’ and ‘limma’ packages in R to screen pathways with significant differences (p < 0.05 and |log2FC|> 0.5), and the results were displayed with the ‘pheatmap’ package [23, 28].

Immune cell infiltration analysis

Many algorithms have been developed to evaluate the infiltration level of immune cell populations, among which CIBERSORT, single-sample GSEA (ssGSEA), and xCell are the most widely used research methods [31, 32]. For CIBERSORT, we estimated the proportion of 22 immune cell populations in the samples using the support vector regression machine learning method with the ‘cibersort’ package in R [33]. For ssGSEA, we compared 28 types of immune cell characteristic gene sets and converted the gene expression values of samples into the enrichment fraction to obtain the relative abundance of immune cells in samples using the ‘gsva’ package in R [34]. For xCell, we performed a cell type enrichment analysis from the gene expression data of 64 immune and stromal cell types using the ‘xcell’ package in R. We subsequently identified immune cell types that were significantly different in CAC and normal tissue using the Wilcoxon test.

ceRNA network construction

ENCORI (http://starbase.sysu.edu.cn/) is a comprehensive database that provides experimentally supported miRNA-mRNA and miRNA-long non-coding RNA (lncRNA) interaction networks [35]. In addition, it integrates information from multiple miRNA-mRNA prediction databases, including PITA, miRmap, miRanda, and TargetScan. To ensure the accuracy of predicting target genes, only those that existed in the four above-mentioned databases were included in the regulatory network. Subsequently, differentially expressed mRNAs (DEmRNAs) were intersected with predicted mRNAs to explore differentially expressed miRNA-mRNA regulatory relationship pairs in CAC. Next, the roles of differentially expressed miRNAs (DEmiRNAs) and lncRNAs were predicted using the ENCORI and LncBase databases [36]. The network was constructed by screening out the lncRNA-miRNA-mRNA regulatory axis that was regulated by the same DEmiRNAs and visualized in Cytoscape 3.8.2 [37]. To further identify the key targets in the process of CAC, the Cytoscape plugin ‘Cytohubba’ was used to perform non-weighted parameter analysis of node connectivity in the network [38]. Finally, the subnetwork was screened according to the connectivity score. Based on the ceRNA hypothesis, lncRNA plays a sponge adsorption role in the cytoplasm and is positively correlated with mRNA expression levels. Therefore, we used LNCipedia (https://Incipedia.org/) to obtain the lncRNA sequence and determine its cellular location using the lncLocator database (http://www.csbio.sjtu.edu.cn/bioinf/lncLocator/) [39, 40]. Co-expression analysis of lncRNA and mRNA was performed based on The Cancer Genome Atlas colorectal cancer data compiled by the ENCORI database. Additionally, CentroidFold (http://rtools.cbrc.jp/centroidfold/) was used to predict the secondary structure of the miRNA precursor stem-loop [41]. Statistical significance was set at p < 0.05.

Statistical analysis

Data analysis was performed with R 4.0.3. The Wilcoxon test was used to compare the types of immune cells in the CAC and NC groups. Spearman’s correlation analysis was used to assess the correlation between the two groups. The chi-square test was used for categorical variables. Statistical significance was set at p < 0.05.

Results

Chip quality analysis

To evaluate the quality of the chip and increase the reliability of the results, we compared the differences in raw data obtained from the GSE37283 dataset of the GEO database before and after correction using boxplots, smoothed histograms, principal component analysis (PCA), and array clustering heatmaps. Boxplots detected outliers by calculating the distribution of each array using pooled data, whereas the smoothed histograms estimated the density of data to indicate the chip quality-related phenomenon. We found many raw data outliers and large differences in density curves among samples that required normalization to eliminate the effect of systematic errors (Fig. 2A–D). Therefore, PCA and array clustering heatmaps were used to describe batch effects among samples (Fig. 2E–G). Although the influence of the batch effect was markedly reduced, restoring the actual biological characteristics of the chip, there were still two abnormal samples (GSM915458 and GSM915469) in the corrected data (Table 1). Overall, these results showed that two outliers must be removed to ensure the reliability of subsequent analysis based on the chip quality control method.

Table 1

Overview of chip quality control

Array	Samplenames	*1	*2	*3	Group
1	GSM915451	–	–	–	UC
2	GSM915452	–	–	–	UC
3	GSM915453	–	–	–	UC
4	GSM915454	–	–	–	UC
5	GSM915455	–	–	–	NC
6	GSM915456	–	–	–	NC
7	GSM915457	–	–	–	NC
8	GSM915458	–	–	√	NC
9	GSM915459	–	–	–	NC
10	GSM915460	–	–	–	CAC
11	GSM915461	–	–	–	CAC
12	GSM915462	–	–	–	CAC
13	GSM915463	–	–	–	CAC
14	GSM915464	–	–	–	CAC
15	GSM915465	–	–	–	CAC
16	GSM915466	–	–	–	CAC
17	GSM915467	–	–	–	CAC
18	GSM915468	–	–	–	CAC
19	GSM915469	–	–	√	CAC
20	GSM915470	–	–	–	CAC

Columns named as *1, *2, and *3 indicate calls from different outlier detection methods: (1) outlier detection by boxplots; (2) outlier detection by distances between arrays (density plots); and (3) batch effect detection using principal component analysis plots and array clustering heatmaps. “√” indicates the presence of an outlier; “–” indicates the absence of an outlier

UC ulcerative colitis, NC normal control, CAC ulcerative colitis-associated colorectal cancer

Weighted co-expression network construction and identification of key modules

After the analysis of variance (ANOVA), the top 25% of genes (4980 genes) from the 18 samples screened for sequencing were subjected to WGCNA to identify genes highly associated with CAC. To define the adjacency matrix, we introduced weight parameters when soft-thresholded β = 16 (scale-free R² > 0.8) and scale-free networks were constructed (Fig. 3A). The dynamic tree-cutting algorithm classified the 4980 genes into 10 co-expression modules (Fig. 3B; Additional file 1: Table S1). By calculating the correlation of each module with the corresponding clinical features, we found that genes in the MEturquoise module were most strongly associated with CAC (r = 0.84, p < 0.01) and were identified as key modules in the CAC process (Fig. 3C, D). The MEturquoise module contained 2264 genes. Further statistical tests on the gene significance (GS) of MEturquoise module membership (MM) and CAC showed that 2264 genes contributed significantly to the membership of the MEturquoise module and CAC (r = 0.87, p < 0.01) (Fig. 3E). Moreover, hierarchical clustering analysis of gene expression levels in the MEturquoise module revealed that gene expression in the CAC group differed from that in the UC and NC groups (Fig. 3F). Therefore, these genes co-expressed with CAC require further study.

GSVA and GSEA reveal CAC-related pathways

Using p < 0.05, and |log2FC|> 0.5, 12 pathways with significant changes were screened out (Fig. 4A; Table 2). According to the threshold value (p adjust < 0.05), we obtained the top 10 pathways with normalized enrichment scores from the results of GSEA. By combining the results of GSEA and GSVA, we found that TNFα signaling via the NF-κB pathway showed significant changes in CAC and had the highest degree of enrichment (normalize enrichment score: 2.285) (Fig. 4B).

Table 2

Differentially expressed pathways in gene set variation analysis

Pathway name	Type	Log2FC	p-value	Adj.p.val
INTERFERON_ALPHA_RESPONSE	Up	0.634121921	4.59E−05	0.000286711
INTERFERON_GAMMA_RESPONSE	Up	0.624598993	2.25E−05	0.000160714
IL6_JAK_STAT3_SIGNALING	Up	0.607187614	2.20E−05	0.000160714
UNFOLDED_PROTEIN_RESPONSE	Up	0.582015106	2.21E−06	6.29E−05
MTORC1_SIGNALING	Up	0.574645409	2.51E−06	6.29E−05
TNFA_SIGNALING_VIA_NFKB	Up	0.565526025	0.000174553	0.000809951
ALLOGRAFT_REJECTION	Up	0.555113783	8.06E−05	0.00044773
MYC_TARGETS_V1	Up	0.535347867	1.26E−05	0.000156916
REACTIVE_OXYGEN_SPECIES_PATHWAY	Up	0.517546923	8.42E−06	0.00014027
EPITHELIAL_MESENCHYMAL_TRANSITION	Up	0.508782095	0.000178189	0.000809951
INFLAMMATORY_RESPONSE	Up	0.505207341	0.000244903	0.000941935
COMPLEMENT	Up	0.502336993	1.98E−05	0.000160714

We performed differential expression analysis of the GSE37283 microarray expression matrix and filtered out 1271 DEGs, which met the criteria (p < 0.05, |log2FC|> 1) between the CAC and NC groups; of these genes, 1012 were upregulated and 258 were downregulated (Fig. 5A). Subsequent hierarchical clustering analysis of the 1270 DEGs revealed significantly different expression between the two groups (Fig. 5B). We then intersected 1793 immune genes downloaded from the Immport database, 2252 genes obtained from CAC modules in WGCNA, and DEGs to identify 130 HIGs (Fig. 5C; Additional file 1: Table S2). Based on the importance of HIGs in CAC, we explored agents that could reverse gene expression and showed therapeutic potential. Four drugs from the Cmap database met the criteria (enrichment < −0.7 and p < 0.01), and their three-dimensional molecular structures were displayed in the PubChem database (Fig. 5D–G; Table 3).

Table 3

Potential drugs with therapeutic potential for ulcerative colitis-associated colorectal cancer

Cmap name	Mean	N	Enrichment score	p	Specificity score	Percent non-null
Metronidazole	− 0.37	5	− 0.836	0.00032	0	80
3-Acetamidocoumarin	− 0.252	4	− 0.819	0.00203	0.039	50
Heptaminol	− 0.281	5	− 0.735	0.00272	0.0206	60
Isometheptene	− 0.23	4	− 0.799	0.00322	0.0138	50

Mean, average connectivity score; N number of instances

Identification of differentially expressed miRNA and ceRNA network construction

We obtained 23 DEmiRNAs (17 upregulated and six downregulated) from the GSE68306 dataset using the same differential analysis method (Fig. 6A, B). Guided by the ceRNA hypothesis, we reversely predicted the mRNAs and lncRNAs downstream and upstream of the 23 miRNAs, respectively. Based on the ENCORI database, DEmiRNAs were matched with the potential mRNAs. Next, we matched the predicted target genes with the HIGs and identified eight pairs of miRNA-mRNAs, which contained four DEmiRNAs and six mRNAs. Next, based on the predicted lncRNAs upstream of the four DEmiRNAs, we used the intersection of the ENCORI and LncBase databases to identify 63 pairs of lncRNAs-miRNAs, including 56 lncRNAs. Finally, we integrated 56 lncRNAs, four miRNAs, and six targeted HIGs into a lncRNA-miRNA-mRNA network (Fig. 6C). Each node of the network was subjected to connectivity analysis using cytohubba, resulting in a subnetwork containing 10 nodes (Fig. 6D; Table 4). Overall, the ceRNA regulatory axis in the subnetwork may be closely related to the occurrence and development of CAC (Fig. 6E).

Table 4

Competing endogenous RNA immune regulatory subnetwork

Name	Type	Degree	MCC
hsa-miR-23a-3p	miRNA	25	25
hsa-miR-1-3p	miRNA	21	21
hsa-miR-145-5p	miRNA	20	20
hsa-miR-133a-3p	miRNA	5	5
NEAT1	lncRNA	3	3
IL6ST	mRNA	2	2
TGFBR2	mRNA	2	2
MAGI2-AS3	lncRNA	2	2
KCNQ1OT1	lncRNA	2	2
MEG3	lncRNA	2	2

MCC maximal clique centrality

Immune landscape of CAC

Previous studies demonstrated that inflammation or tumor initiation and progression are associated with the immune microenvironment and that immunocytes are key components in the microenvironment [42]. Therefore, exploration of the immune landscape in CAC is highly warranted. We first performed ssGSEA to quantify the relative abundance of immune cell infiltration in the CAC group compared to in the NC group (Fig. 7A). Wilcoxon analysis showed that 22 types of immune cells were significantly different between the two groups (p < 0.05) (Fig. 7B). Subsequently, CIBERSORT and xCell were used to evaluate immune cell infiltration and reduce bias before visualization in heatmaps (Fig. 7C, D). The most important observation from data comparison was that the neutrophils were the central immune cells, as they were the only cells showing the same trend in differential expression across the three algorithms.

Identification and verification of a ceRNA-immunoregulation axis

Overall, the significant difference between the NF-κB pathway and neutrophils in CAC indirectly demonstrated that both factors play critical roles in CAC formation. Consequently, we carried out correlation analysis, which showed that the NF-κB pathway was significantly positively correlated with neutrophils (r = 0.79, p < 0.01) (Fig. 8A). We also intersected the core genes enriched in the NF-κB pathway with HIGs to obtain two key immune genes, IL6ST and TNFAIP3. Of these, IL6ST was significantly positively correlated with neutrophils (r = 0.75, p < 0.01) (Fig. 8B). To further analyze the regulatory mechanism of IL6ST at the transcriptional level in the ceRNA immunoregulatory network, we identified two upstream lncRNAs, NEAT1 and KCNQ1OT1 that regulate IL6ST. The mechanism of lncRNA is related to its localization in cells [43]. We predicted the subcellular localization of lncRNAs using the lnclocator algorithm. NEAT1 was mainly distributed in the cytoplasm, whereas KCNQ1OT1 in the nucleus (Fig. 8C). Using the ENCORI database, we verified that NEAT1 promotes the expression of the target mRNA IL6ST (Fig. 8D). We then predicted the precursor stem loop structures for the two target miRNAs of NEAT1 (Additional file 2: Fig. S1). Compared with miR-133a-3p, miR-1-3p had the highest connectivity score in the ceRNA network and a higher predictive score for interacting with NEAT1. These results indicate that NEAT1 absorbs miR-1-3p through sponge action to increase the expression of IL6ST (Fig. 8E).

Discussion

UC is a chronic inflammatory disease of unknown etiology, and its cumulative incidence of progressing to CAC has markedly increased over the years [44]. Because of chronic inflammation caused by UC, various layers of the intestinal wall are infiltrated by immune cells, forming an immune microenvironment and participating in the induction of CAC through the production of cytokines and chemokines [45]. However, the underlying mechanisms remain unclear. Here, we explored the role of the ceRNA-immunoregulatory axis in the immune regulation of CAC at the transcriptional level.

We integrated three bioinformatics methods, including immune gene list, WGCNA, and differential gene expression analysis, to identify 130 HIGs. We found that metronidazole, 3-acetamidocoumarin, heptaminol, and isometheteptene reversed the expression levels of HIGs and play a potential role in the treatment of CAC. Compared with the other three drugs not reported in CAC, metronidazole has been shown to inhibit the occurrence of tumors and reduce the degree of inflammation in CAC animal models [46]. Based on the ceRNA hypothesis, we predicted miRNAs and lncRNAs using HIGs and constructed a ceRNA-immunoregulatory network to better understand the CAC-related molecular mechanisms and biological phenomena at the transcriptional level.

To determine the underlying mechanisms affecting the occurrence of CAC, we analyzed the differences in pathways between the CAC and NC groups using two major pathway enrichment methods. The results showed that the largest number of genes (93 genes) was enriched in the NF-κB pathway, revealing that this pathway is closely related to CAC. The NF-κB pathway is involved in the immune response in vivo through classical and non-classical pathways, allowing the massive release of pro-inflammatory cytokines that cause tissue damage and participate in tumor invasion and metastasis by regulating the expression of angiogenesis-related genes [47‐50]. A previous study showed that the NF-κB pathway exerts a tumor-promoting effect in a CAC mouse model [51].

We further evaluated alterations in the immune microenvironment of CAC and found that only neutrophils had the same expression trend (high in the CAC group and low in the NC group) across the three methods used to calculate the degree of immune cell infiltration. These results were consistent with those reported in previous studies showing that neutrophil infiltration is significantly higher in the colonic mucosal layer of a CAC mouse model, promoting CAC occurrence by secreting chemokines and, consequently, recruiting chemotactic receptors [52, 53]. Correlation analysis showed that the NF-κB pathway was positively correlated with neutrophils. Further analysis of 93 core genes enriched in the NF-κB pathway revealed that IL6ST was positively associated with neutrophils. We subsequently screened the miRNAs regulating IL6ST (miR-1-3p) and its upstream lncRNA from the ceRNA network (NEAT1). Previous studies suggested that NEAT1 promotes tumor development by downregulating target miRNAs. Zhou et al. [54] reported that NEAT1 targets and downregulates miR-500a-3p, promoting gastric cancer cell proliferation and invasion; Huang et al. [55] suggested that NEAT1 promotes pancreatic cancer progression by negatively regulating miR-506-3p; whereas Zhang et al. [56] showed that upregulation of NEAT1 is involved in the proliferation of glioma cells by negatively regulating miR-324-5p. However, the role of NEAT1 in CAC has rarely been reported. MiR-1-3p, a downstream target of NEAT1, has been shown to play a facilitative role in tumors. For instance, Peng et al. [57] reported that miR-1-3p affects gastric cancer cell proliferation by promoting the oxygen glycolytic pathway, and Liu et al. [58] indicated that downregulation of miR-1-3p expression is involved in the growth and motility of lung cancer cells. Our results suggest that IL6ST is a target gene of miR-1-3p in CAC. IL6ST is a subunit of the IL-6 receptor, and the IL-6/IL-6 receptor complex only functions by binding to IL6ST [59]. Previous studies showed that IL-6 promotes the occurrence of CAC by interacting with IL6ST [60]. Our data further supported that NEAT1 can competitively bind to miR-1-3p and upregulate IL6ST at the transcriptional level, affecting the NF-κB pathway and neutrophil infiltration as well as promoting the occurrence and development of CAC.

We constructed a ceRNA-immunoregulatory network by integrating multiple bioinformatics tools and deeply analyzed the alterations of the immune microenvironment and pathways in the process of CAC. Ultimately, we identified a ceRNA immunoregulatory axis closely related to CAC. However, our study had some limitations; (1) we only used public datasets for the analysis, which may be biased because of the limited sample size. (2) Although we conducted a bioinformatic analysis and database prediction, the direct relationship between the ceRNA immunoregulatory axes requires experimental verification. (3) In vivo and in vitro functional experiments are needed to determine the biological role of the ceRNA regulatory axis in CAC. (4) Currently, bioinformatic analysis for the prediction of drug utility is limited; however, we believe that this study may provide valuable insights in designing drugs to treat CAC.

Conclusion

In conclusion, we identified a ceRNA immunoregulatory network of CAC and suggested that the NEAT1/miR-1-3p/IL6ST regulatory axis participates in the CAC process by altering neutrophil infiltration in the immune microenvironment. These findings provide a new perspective and direction for further exploration of the immunoregulatory mechanisms underlying CAC.

Acknowledgements

The authors would like to thank all staff members in the Department of Colorectal Surgery at the Sixth Affiliated Hospital of Sun Yat-sen University.

Declarations

The study was conducted in accordance with the guidelines of the Declaration of Helsinki and approved by the Medical Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China (no. 2021ZSLYEC-006).

Not applicable.

Competing interests

Not applicable.

Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1. Table S1: Number of genes in the 10 modules. Table S2: List of 130 hub immune genes.

Additional file 2. Fig. S1: shows the stem-loop structure of miRNA precursors. (A) Secondary structures of human pre‐miR‐1. (B) Secondary structures of human pre‐miR‐133a.

Neurath MF. Targeting immune cell circuits and trafficking in inflammatory bowel disease. Nat Immunol. 2019;20:970–9. https://doi.org/10.1038/s41590-019-0415-0.CrossRefPubMed

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. https://doi.org/10.1016/j.cell.2011.02.013.CrossRefPubMed

Ma L, Weinberg RA. MicroRNAs in malignant progression. Cell Cycle. 2008;7:570–2.CrossRefPubMed

Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature. 2014;505:344–52. https://doi.org/10.1038/nature12986.CrossRefPubMedPubMedCentral

Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281–97.CrossRefPubMed

Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009. https://doi.org/10.1101/gr.082701.108.CrossRefPubMedPubMedCentral

Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–8. https://doi.org/10.1016/j.cell.2011.07.014.CrossRefPubMedPubMedCentral

Chan JJ, Tay Y. Noncoding RNA:RNA regulatory networks in cancer. Int J Mol Sci. 2018. https://doi.org/10.3390/ijms19051310.CrossRefPubMedPubMedCentral

Zhang K, Zhang L, Mi Y, Tang Y, Ren F, Liu B, Zhang Y, Zheng P. A ceRNA network and a potential regulatory axis in gastric cancer with different degrees of immune cell infiltration. Cancer Sci. 2020;111:4041–50. https://doi.org/10.1111/cas.14634.CrossRefPubMedPubMedCentral

10.

Zhang L, Zhang K, Liu S, Zhang R, Yang Y, Wang Q, Zhao S, Yang L, Zhang Y, Wang J. Identification of a ceRNA network in lung adenocarcinoma based on integration analysis of tumor-associated macrophage signature genes. Front Cell Dev Biol. 2021;9: 629941. https://doi.org/10.3389/fcell.2021.629941.CrossRefPubMedPubMedCentral

11.

Luo X, Peng S, Ding S, Zeng Q, Wang R, Ma Y, Chen S, Wang Y, Wang W. Prognostic values, ceRNA network, and immune regulation function of SDPR in KRAS-mutant lung cancer. Cancer Cell Int. 2021;21:49. https://doi.org/10.1186/s12935-021-01756-8.CrossRefPubMedPubMedCentral

12.

Qi X, Zhang D-H, Wu N, Xiao J-H, Wang X, Ma W. ceRNA in cancer: possible functions and clinical implications. J Med Genet. 2015;52:710–8. https://doi.org/10.1136/jmedgenet-2015-103334.CrossRefPubMed

13.

Sun F, Liang W, Tang K, Hong M, Qian J. Profiling the lncRNA-miRNA-mRNA ceRNA network to reveal potential crosstalk between inflammatory bowel disease and colorectal cancer. PeerJ. 2019;7: e7451. https://doi.org/10.7717/peerj.7451.CrossRefPubMedPubMedCentral

14.

Jiang H, Wu F, Jiang N, Gao J, Zhang J. Reconstruction and analysis of competitive endogenous RNA network reveals regulatory role of long non-coding RNAs in hepatic fibrosis. Mol Med Rep. 2019;20:4091–100. https://doi.org/10.3892/mmr.2019.10682.CrossRefPubMedPubMedCentral

15.

He L, Chen Y, Hao S, Qian J. Uncovering novel landscape of cardiovascular diseases and therapeutic targets for cardioprotection via long noncoding RNA-miRNA-mRNA axes. Epigenomics. 2018;10:661–71. https://doi.org/10.2217/epi-2017-0176.CrossRefPubMed

16.

Pekow J, Dougherty U, Huang Y, Gometz E, Nathanson J, Cohen G, Levy S, Kocherginsky M, Venu N, Westerhoff M, et al. Gene signature distinguishes patients with chronic ulcerative colitis harboring remote neoplastic lesions. Inflamm Bowel Dis. 2013;19:461–70. https://doi.org/10.1097/MIB.0b013e3182802bac.CrossRefPubMed

17.

Pekow J, Meckel K, Dougherty U, Huang Y, Chen X, Almoghrabi A, Mustafi R, Ayaloglu-Butun F, Deng Z, Haider HI, et al. miR-193a-3p is a key tumor suppressor in ulcerative colitis-associated colon cancer and promotes carcinogenesis through upregulation of IL17RD. Clin Cancer Res. 2017;23:5281–91. https://doi.org/10.1158/1078-0432.CCR-17-0171.CrossRefPubMedPubMedCentral

18.

Gautier L, Cope L, Bolstad BM, Irizarry RA. affy–analysis of Affymetrix GeneChip data at the probe level. Bioinformatics. 2004;20:307–15.CrossRefPubMed

19.

Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 2003;4:249–64.CrossRefPubMed

20.

Kauffmann A, Gentleman R, Huber W. arrayQualityMetrics—a bioconductor package for quality assessment of microarray data. Bioinformatics. 2009;25:415–6. https://doi.org/10.1093/bioinformatics/btn647.CrossRefPubMed

21.

Bhattacharya S, Dunn P, Thomas CG, Smith B, Schaefer H, Chen J, Hu Z, Zalocusky KA, Shankar RD, Shen-Orr SS, et al. ImmPort, toward repurposing of open access immunological assay data for translational and clinical research. Sci Data. 2018;5: 180015. https://doi.org/10.1038/sdata.2018.15.CrossRefPubMedPubMedCentral

22.

Langfelder P, Horvath S. WGCNA: an R package for weighted correlation network analysis. BMC Bioinform. 2008;9:559. https://doi.org/10.1186/1471-2105-9-559.CrossRef

23.

Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, Smyth GK. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47. https://doi.org/10.1093/nar/gkv007.CrossRefPubMedPubMedCentral

24.

Bardou P, Mariette J, Escudié F, Djemiel C, Klopp C. jvenn: an interactive Venn diagram viewer. BMC Bioinform. 2014;15:293. https://doi.org/10.1186/1471-2105-15-293.CrossRef

25.

Lamb J, Crawford ED, Peck D, Modell JW, Blat IC, Wrobel MJ, Lerner J, Brunet J-P, Subramanian A, Ross KN, et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science. 2006;313:1929–35.CrossRefPubMed

26.

Kim S, Chen J, Cheng T, Gindulyte A, He J, He S, Li Q, Shoemaker BA, Thiessen PA, Yu B, et al. PubChem in 2021: new data content and improved web interfaces. Nucleic Acids Res. 2021;49:D1388–95. https://doi.org/10.1093/nar/gkaa971.CrossRefPubMed

27.

Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545–50.CrossRefPubMedPubMedCentral

28.

Hänzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinform. 2013;14:7. https://doi.org/10.1186/1471-2105-14-7.CrossRef

29.

Liberzon A, Birger C, Thorvaldsdóttir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1:417–25.CrossRefPubMedPubMedCentral

30.

Yu G, Wang L-G, Han Y, He Q-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7. https://doi.org/10.1089/omi.2011.0118.CrossRefPubMedPubMedCentral

31.

Newman AM, Liu CL, Green MR, Gentles AJ, Feng W, Xu Y, Hoang CD, Diehn M, Alizadeh AA. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12:453–7. https://doi.org/10.1038/nmeth.3337.CrossRefPubMedPubMedCentral

32.

Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18:220. https://doi.org/10.1186/s13059-017-1349-1.CrossRefPubMedPubMedCentral

33.

Scholkopf A, Smola F, Williamson S, Bartlett S. New support vector algorithms. Neural Comput. 2000;12:1207–45.CrossRefPubMed

34.

Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T, Lafontaine L, Berger A, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39:782–95. https://doi.org/10.1016/j.immuni.2013.10.003.CrossRefPubMed

35.

Li J-H, Liu S, Zhou H, Qu L-H, Yang J-H. starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42:D92–7. https://doi.org/10.1093/nar/gkt1248.CrossRefPubMed

36.

Paraskevopoulou MD, Vlachos IS, Karagkouni D, Georgakilas G, Kanellos I, Vergoulis T, Zagganas K, Tsanakas P, Floros E, Dalamagas T, et al. DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts. Nucleic Acids Res. 2016;44:D231–8. https://doi.org/10.1093/nar/gkv1270.CrossRefPubMed

37.

Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13:2498–504.CrossRefPubMedPubMedCentral

38.

Chin C-H, Chen S-H, Wu H-H, Ho C-W, Ko M-T, Lin C-Y. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. https://doi.org/10.1186/1752-0509-8-S4-S11.CrossRefPubMedPubMedCentral

39.

Volders P-J, Anckaert J, Verheggen K, Nuytens J, Martens L, Mestdagh P, Vandesompele J. LNCipedia 5: towards a reference set of human long non-coding RNAs. Nucleic Acids Res. 2019;47:D135–9. https://doi.org/10.1093/nar/gky1031.CrossRefPubMed

40.

Lin Y, Pan X, Shen H-B. lncLocator 2.0: a cell-line-specific subcellular localization predictor for long non-coding RNAs with interpretable deep learning. Bioinformatics. 2021. https://doi.org/10.1093/bioinformatics/btab127.CrossRefPubMedPubMedCentral

41.

Sato K, Hamada M, Asai K, Mituyama T. CENTROIDFOLD: a web server for RNA secondary structure prediction. Nucleic Acids Res. 2009;37:W277–80. https://doi.org/10.1093/nar/gkp367.CrossRefPubMedPubMedCentral

42.

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883–99. https://doi.org/10.1016/j.cell.2010.01.025.CrossRefPubMedPubMedCentral

43.

Geisler S, Coller J. RNA in unexpected places: long non-coding RNA functions in diverse cellular contexts. Nat Rev Mol Cell Biol. 2013;14:699–712. https://doi.org/10.1038/nrm3679.CrossRefPubMedPubMedCentral

44.

Choi C-HR, Rutter MD, Askari A, Lee GH, Warusavitarne J, Moorghen M, Thomas-Gibson S, Saunders BP, Graham TA, Hart AL. Forty-year analysis of colonoscopic surveillance program for neoplasia in ulcerative colitis: an updated overview. Am J Gastroenterol. 2015;110:1022–34. https://doi.org/10.1038/ajg.2015.65.CrossRefPubMedPubMedCentral

45.

Francescone R, Hou V, Grivennikov SI. Cytokines, IBD, and colitis-associated cancer. Inflamm Bowel Dis. 2015;21:409–18. https://doi.org/10.1097/MIB.0000000000000236.CrossRefPubMed

46.

Lee JG, Lee Y-R, Lee AR, Park CH, Han DS, Eun CS. Role of the global gut microbial community in the development of colitis-associated cancer in a murine model. Biomed Pharmacother. 2021;135: 111206. https://doi.org/10.1016/j.biopha.2020.111206.CrossRefPubMed

47.

Atreya I, Atreya R, Neurath MF. NF-kappaB in inflammatory bowel disease. J Intern Med. 2008;263:591–6. https://doi.org/10.1111/j.1365-2796.2008.01953.x.CrossRefPubMed

48.

O’Connor PM, Lapointe TK, Beck PL, Buret AG. Mechanisms by which inflammation may increase intestinal cancer risk in inflammatory bowel disease. Inflamm Bowel Dis. 2010;16:1411–20. https://doi.org/10.1002/ibd.21217.CrossRefPubMed

49.

Wang S, Liu Z, Wang L, Zhang X. NF-kappaB signaling pathway, inflammation and colorectal cancer. Cell Mol Immunol. 2009;6:327–34. https://doi.org/10.1038/cmi.2009.43.CrossRefPubMedPubMedCentral

50.

Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5:749–59.CrossRefPubMed

51.

Greten FR, Eckmann L, Greten TF, Park JM, Li Z-W, Egan LJ, Kagnoff MF, Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell. 2004;118:285–96.CrossRefPubMed

52.

Lin Y, Cheng L, Liu Y, Wang Y, Wang Q, Wang HL, Shi G, Li JS, Wang QN, Yang QM, et al. Intestinal epithelium-derived BATF3 promotes colitis-associated colon cancer through facilitating CXCL5-mediated neutrophils recruitment. Mucosal Immunol. 2021;14:187–98. https://doi.org/10.1038/s41385-020-0297-3.CrossRefPubMed

53.

Shang K, Bai Y-P, Wang C, Wang Z, Gu H-Y, Du X, Zhou X-Y, Zheng C-L, Chi Y-Y, Mukaida N, et al. Crucial involvement of tumor-associated neutrophils in the regulation of chronic colitis-associated carcinogenesis in mice. PLoS ONE. 2012;7: e51848. https://doi.org/10.1371/journal.pone.0051848.CrossRefPubMedPubMedCentral

54.

Zhou Y, Sha Z, Yang Y, Wu S, Chen H. lncRNA NEAT1 regulates gastric carcinoma cell proliferation, invasion and apoptosis via the miR-500a-3p/XBP-1 axis. Mol Med Rep. 2021. https://doi.org/10.3892/mmr.2021.12142.CrossRefPubMedPubMedCentral

55.

Huang B, Liu C, Wu Q, Zhang J, Min Q, Sheng T, Wang X, Zou Y. Long non-coding RNA NEAT1 facilitates pancreatic cancer progression through negative modulation of miR-506-3p. Biochem Biophys Res Commun. 2017;482:828–34. https://doi.org/10.1016/j.bbrc.2016.11.120.CrossRefPubMed

56.

Zhang J, Li Y, Liu Y, Xu G, Hei Y, Lu X, Liu W. Long non-coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA-324–5p and upregulating KCTD20 expression. Oncol Rep. 2021. https://doi.org/10.3892/or.2021.8076.CrossRefPubMedPubMedCentral

57.

Deng P, Li K, Gu F, Zhang T, Zhao W, Sun M, Hou B. LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis. Mol Med. 2021;27:9. https://doi.org/10.1186/s10020-020-00259-y.CrossRefPubMedPubMedCentral

58.

Liu P-J, Chen Y-H, Tsai K-W, Yeah H-Y, Yeh C-Y, Tu Y-T, Yang C-Y. Involvement of MicroRNA-1-FAM83A axis dysfunction in the growth and motility of lung cancer cells. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21228833.CrossRefPubMedPubMedCentral

59.

Kidd VJ, Nesbitt JE, Fuller GM. Chromosomal localization of the IL-6 receptor signal transducing subunit, gp130 (IL6ST). Somat Cell Mol Genet. 1992;18:477–83.CrossRefPubMed

60.

Hirano T, Hirayama D, Wagatsuma K, Yamakawa T, Yokoyama Y, Nakase H. Immunological mechanisms in inflammation-associated colon carcinogenesis. Int J Mol Sci. 2020. https://doi.org/10.3390/ijms21093062.CrossRefPubMedPubMedCentral

Titel: A novel ceRNA-immunoregulatory axis based on immune cell infiltration in ulcerative colitis-associated colorectal carcinoma by integrated weighted gene co-expression network analysis
verfasst von: Shi Yin
Xianzhe Li
Zhizhong Xiong
Minghao Xie
Longyang Jin
Huaxian Chen
Chaobin Mao
Fengxiang Zhang
Lei Lian
Publikationsdatum: 01.12.2022
Verlag: BioMed Central
Erschienen in: BMC Gastroenterology / Ausgabe 1/2022
Elektronische ISSN: 1471-230X
DOI: https://doi.org/10.1186/s12876-022-02252-7

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Supplementary Information

Publisher's Note

Background

Methods

Data acquisition and preprocessing

Construction of weighted gene co-expression gene network

Differential expression analysis and identification of hub immune genes

Small-molecule drug prediction

Gene set enrichment analysis

Immune cell infiltration analysis

ceRNA network construction

Statistical analysis

Results

Chip quality analysis

Weighted co-expression network construction and identification of key modules

GSVA and GSEA reveal CAC-related pathways

Identification of CAC-related hub immune genes and small molecule therapeutic drug prediction

Identification of differentially expressed miRNA and ceRNA network construction

Immune landscape of CAC

Identification and verification of a ceRNA-immunoregulation axis

Discussion

Conclusion

Acknowledgements

Declarations

Ethics approval and consent to participate

Consent for publication

Competing interests

Publisher's Note

Supplementary Information

Weitere Artikel der Ausgabe 1/2022

Near-infrared fluorescence imaging with indocyanine green for assessment of donor livers in a rat model of ischemia–reperfusion

Endoscopic features of oxyntic gland adenoma and gastric adenocarcinoma of the fundic gland type differ between patients with and without Helicobacter pylori infection: a retrospective observational study

A nomogram for predicting survival in patients with advanced (stage III/IV) pancreatic body tail cancer: a SEER-based study

Uncommon cause of respiratory failure due to a bezoar in the hypopharynx: a case report

Metabolism reprogramming signature associated with stromal cells abundance in tumor microenvironment improve prognostic risk classification for gastric cancer

Hypomagnesemia in intestinal lymphangiectasia: a case report and review of the literature

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

Update Innere Medizin